Literature DB >> 23402825

Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.

Anne Derbise1, François Pierre, Maud Merchez, Elizabeth Pradel, Sabrina Laouami, Isabelle Ricard, Jean-Claude Sirard, Jill Fritz, Nadine Lemaître, Henry Akinbi, Ivo G Boneca, Florent Sebbane.   

Abstract

BACKGROUND: Yersinia pestis (the plague bacillus) and its ancestor, Yersinia pseudotuberculosis (which causes self-limited bowel disease), encode putative homologues of the periplasmic lysozyme inhibitor Ivy and the membrane-bound lysozyme inhibitor MliC. The involvement of both inhibitors in virulence remains subject to debate.
METHODS: Mutants lacking ivy and/or mliC were generated. We evaluated the mutants' ability to counter lysozyme, grow in serum, and/or counter leukocytes; to produce disease in wild-type, neutropenic, or lysozyme-deficient rodents; and to induce host inflammation.
RESULTS: MliC was not required for lysozyme resistance and the development of plague. Deletion of ivy decreased Y. pestis' ability to counter lysozyme and polymorphonuclear neutrophils, but it did not affect the bacterium's ability to grow in serum or resist macrophages. Y. pestis lacking Ivy had attenuated virulence, unless animals were neutropenic or lysozyme deficient. The Ivy mutant induced inflammation to a degree similar to that of the parental strain. Last, Y. pseudotuberculosis did not require Ivy to counter lysozyme and for virulence.
CONCLUSIONS: Ivy is required to counter lysozyme during infection, but its role as a virulence factor is species dependent. Our study also shows that a gene that is not necessary for the virulence of an ancestral bacterium may become essential in the emergence of a new pathogen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402825     DOI: 10.1093/infdis/jit057

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

2.  Edwardsiella tarda MliC, a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy.

Authors:  Mo-Fei Li; Chong Wang; Li Sun
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

3.  Edwardsiella tarda Ivy, a lysozyme inhibitor that blocks the lytic effect of lysozyme and facilitates host infection in a manner that is dependent on the conserved cysteine residue.

Authors:  Chong Wang; Yong-hua Hu; Bo-guang Sun; Jun Li; Li Sun
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

4.  New insights into how Yersinia pestis adapts to its mammalian host during bubonic plague.

Authors:  Elizabeth Pradel; Nadine Lemaître; Maud Merchez; Isabelle Ricard; Angéline Reboul; Amélie Dewitte; Florent Sebbane
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

5.  Long-term persistence of Yersinia pseudotuberculosis in entomopathogenic nematodes.

Authors:  Samuel Gengler; Anne Laudisoit; Henri Batoko; Pierre Wattiau
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

6.  Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system.

Authors:  Gabriel Torrens; Marcelo Pérez-Gallego; Bartolomé Moya; Marta Munar-Bestard; Laura Zamorano; Gabriel Cabot; Jesús Blázquez; Juan A Ayala; Antonio Oliver; Carlos Juan
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

Review 7.  From bacterial killing to immune modulation: Recent insights into the functions of lysozyme.

Authors:  Stephanie A Ragland; Alison K Criss
Journal:  PLoS Pathog       Date:  2017-09-21       Impact factor: 6.823

8.  Neisseria gonorrhoeae employs two protein inhibitors to evade killing by human lysozyme.

Authors:  Stephanie A Ragland; Marίa V Humbert; Myron Christodoulides; Alison K Criss
Journal:  PLoS Pathog       Date:  2018-07-05       Impact factor: 6.823

Review 9.  Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.

Authors:  Christian E Demeure; Olivier Dussurget; Guillem Mas Fiol; Anne-Sophie Le Guern; Cyril Savin; Javier Pizarro-Cerdá
Journal:  Genes Immun       Date:  2019-04-03       Impact factor: 2.676

Review 10.  The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Authors:  John R Brannon; Maria Hadjifrangiskou
Journal:  Drug Des Devel Ther       Date:  2016-05-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.